Regenerative Medical Technologies Group Increases Q1 2025 Sales By 67% Over Q1 2024 and Achieves Operating Profit for the Quarter of $134,000
Regenerative Medical Technologies Group, Inc. $RMTG, a regenerative medicine company, is pleased to announce that